STOCK TITAN

Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) announced it will host a booth at Medlab Middle East 2022, taking place January 24-27 at the Dubai World Trade Centre. The event is a significant gathering for the global medical laboratory community, providing a platform for introducing Co-Diagnostics' products to international clients. Company representatives will showcase innovations, including a new point-of-care and at-home rapid PCR diagnostics platform. Attendees can visit Booth Z6-C26 for more information.

Positive
  • None.
Negative
  • None.

SALT LAKE CITY, Jan. 21, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming Medlab Middle East 2022 trade show held January 24-27 at the Dubai World Trade Centre.

It is expected that the conference, catering to the global medical laboratory community and showcasing the latest in laboratory innovation and technology, will provide opportunities for Company representatives and distributors to introduce Co-Diagnostics products to a wide array of international customers.  

To learn more about the conference, including in-person and virtual registration details, please visit https://www.medlabme.com/en/home.html. Attendees interested in learning more about the Company and its products, including its upcoming point-of-care and at-home rapid PCR diagnostics platform, are invited to visit Booth Z6-C26.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medlab-middle-east-2022-in-dubai-on-january-24-27-301465509.html

SOURCE Co-Diagnostics

FAQ

When is Co-Diagnostics participating in Medlab Middle East 2022?

Co-Diagnostics is participating in Medlab Middle East 2022 from January 24-27, 2022.

Where is the Medlab Middle East 2022 event held?

The Medlab Middle East 2022 event is held at the Dubai World Trade Centre.

What products will Co-Diagnostics showcase at the event?

Co-Diagnostics will showcase its point-of-care and at-home rapid PCR diagnostics platform.

What is the booth number for Co-Diagnostics at Medlab Middle East 2022?

Co-Diagnostics will be located at Booth Z6-C26.

What is the significance of Medlab Middle East 2022 for Co-Diagnostics?

The conference provides an opportunity for Co-Diagnostics to introduce its products to a wide array of international customers and showcase laboratory innovations.

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

34.44M
31.93M
5.4%
14.45%
0.71%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY